Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006

Eurosurveillance

Volumn 16, Issue 44, 2011, Pages

  Sauerbrei, A ^a   Schmitt, S ^b   Scheper, T ^c   Brandstadt A ^a   Saschenbrecker, S ^c   Motz, M ^d   Soutschek, E ^d   Wutzler, P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Sanofi Pasteur MSD GmbH   (Germany)

^c Institute of Experimental Immunology   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN C1; GLYCOPROTEIN G1; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AFFINITY CHROMATOGRAPHY; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD DONOR; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOBLOTTING; INFANT; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; MALE; NEWBORN INFECTION; PREGNANT WOMAN; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROEPIDEMIOLOGY; SEROPREVALENCE; SEX DIFFERENCE; VIRUS TRANSMISSION;

EID: 80455142955     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Chayavichitsilp P, Buckwalter JV, Krakowski AC, Friedlander SF. Herpes simplex. Pediatr Rev. 2009;30(4):119-29.
2. Koelle DM, Wald A. Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother. 2000;45 Suppl T3:1-8.
3. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186 Suppl 1:S3-28.
4. Peña KC, Adelson ME, Mordechai E, Blaho JA. Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States. J Clin Microbiol. 2010;48(1):150-3.
5. Morrow RA, Brown ZA. Common use of inaccurate antibody assays to identify infection status with herpes simplex virus type 2. Am J Obstet Gynecol. 2005;193(2):361-2.
6. Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA. 2011;305(14):1441-9.
7. Sauerbrei A, Wutzler P. Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: herpes simplex virus infections. Med Microbiol Immunol. 2007;196(2):89-94.
8. Rudnick CM, Hoekzema GS. Neonatal herpes simplex virus infections. Am Fam Physician. 2002;6(6):1138-42.
9. Roberts S. Herpes simplex virus: incidence of neonatal herpes simplex virus, maternal screening, management during pregnancy, and HIV. Curr Opin Obstet Gynecol. 2009;21(2):124-30.
10. Wutzler P, Doerr HW, Färber I, Eichhorn U, Helbig B, Sauerbrei A, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol. 2000;61(2):201-7.
11. Buxbaum S, Geers M, Gross G, Schöfer H, Rabenau HF, Doerr HW. Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed? Med Microbiol Immunol. 2003;192(3):177-81.
12. Tunbäck P, Bergström T, Claesson BA, Carlsson RM, Löwhagen GB. Early acquisition of herpes simplex virus type 1 antibodies in children-a longitudinal serological study. J Clin Virol. 2007;40(1):26-30.
13. Gupta R, Warren T, Wald A. Genital herpes. Lancet. 2007;370(9605):2127-37.
14. Bergström T, Trybala E. Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology. Intervirology. 1996;39(3):176-84.
15. Scheper T, Saschenbrecker S, Steinhagen K, Sauerbrei A, Suer W, Meyer W, et al. The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies. J Virol Methods. 2010;166(1-2):42-7.
16. Zentrale Ethikkommission bei der Bundesärztekammer. Die (Weiter-) Verwendung von menschlichen Körpermaterialien für Zwecke der medizinischen Forschung (2003) [The (further) use of human body samples for the purpose of medical research (2003) English translation of the title]. Berlin: Zentrale Ethikkommission bei der Bundesärztekammer, Berlin. [Accessed 15 May 2008]. German. Available from: http://www.zentrale-ethikkommission.de/page.asp?his=0.1.21
17. Ramos S, Lukefahr JL, Morrow RA, Stanberry LR, Rosenthal SL. Prevalence of herpes simplex virus types 1 and 2 among children and adolescents attending a sexual abuse clinic. Pediatr Infect Dis J. 2006;25(10):902-5.
18. Focus Diagnostics. HerpeSelect® 1 ELISA IgG. Cypress: Focus Diagnostics. [Accessed 24 Oct 2011]. Available from: http://www.focusdx.com/pdfs/pi/US/EL0910G.pdf
19. Focus Diagnostics. HerpeSelect® 2 ELISA IgG. Cypress: Focus Diagnostics. [Accessed 24 Oct 2011]. Available from: http://www.focusdx.com/pdfs/pi/US/EL0920G.pdf
20. Mikrogen Diagnostik. recomLine HSV-1 & HSV-2 IgG. Neuried: Mikrogen Diagnostik. [Accessed 24 Oct 2011]. Available from: http://www.mikrogen.de/uploads/tx_oemikrogentables/dokumente/GIRLHSDE.pdf
21. Aarnisalo J, Ilonen J, Vainionpää R, Valonen I, Kaitossaari T, Simell O. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study. Scand J Infect Dis. 2003;35(10):750-3.
22. Davidovici BB, Green M, Marouni MJ, Bassal R, Pimenta JM, Cohen D. Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel. J Infect. 2006;52(5):367-73.
23. Schillinger JA, Xu F, Sternberg MR, Armstrong GL, Lee FK, Nahmias AJ, et al. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm Dis. 2004;31(12):753-60.
24. Clemens SA, Farhat CK. Seroprevalence of herpes simplex 1-2 antibodies in Brazil. Rev Saude Publica. 2010;44(4):726-34.
25. Kasubi MJ, Nilsen A, Marsden HS, Bergström T, Langeland N, Haarr L. Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania. J Clin Microbiol. 2006;44(8):2801-7.
26. Marquez L, Levy ML, Munoz FM, Palazzi DL. A report of three cases and review of intrauterine herpes simplex virus infection. Pediatr Infect Dis J. 2011;30(2):153-7.
27. Anizivino E, Fioriti D, Mischitelli M, Bellizzi A, Barucca V, Chiarini F, et al. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention. Virol J. 2009;6:40.
28. Enders G, Risse B, Zauke M, Bolley I, Knotek F. Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specific enzyme immunoassay. Eur J Clin Microbiol Infect Dis. 1998;17(12):870-2.
29. Pebody RG, Andrews N, Brown D, Gopal R, de Melker H, François G, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect. 2004;80(3):185-91.
30. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chirion HSV Vaccine Study Group. N Engl J Med. 1999;341(19):1432-8.
31. Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect. 2000;76(3):183-7.
32. Ashley RL, Wu L, Pickering JW, Tu MC, Schnorenberg L. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J Clin Microbiol. 1998;36(1):294-5.
33. Martins TB, Woolstenhulme RD, Jaskowski TD, Hill HR, Litwin CM. Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus. Am J Clin Pathol. 2001;115(2):272-7.
34. Sauerbrei A, Wutzler P. Novel recombinant ELISA assays for determination of type-specific IgG antibodies against HSV-1 and HSV-2. J Virol Methods. 2007;144(1-2):138-42.